Previous close | 5.60 |
Open | 6.00 |
Bid | 4.60 |
Ask | 9.40 |
Strike | 270.00 |
Expiry date | 2024-10-18 |
Day's range | 6.00 - 6.00 |
Contract range | N/A |
Volume | |
Open interest | 52 |
GSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval, respectively.
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.